A detailed history of Nuveen Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 5,067,506 shares of LLY stock, worth $4.05 Billion. This represents 1.3% of its overall portfolio holdings.

Number of Shares
5,067,506
Previous 5,155,383 1.7%
Holding current value
$4.05 Billion
Previous $4.67 Billion 3.82%
% of portfolio
1.3%
Previous 1.4%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $67.9 Million - $84.4 Million
-87,877 Reduced 1.7%
5,067,506 $4.49 Billion
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $94.1 Million - $118 Million
-129,843 Reduced 2.46%
5,155,383 $4.67 Billion
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $46.6 Million - $62.4 Million
-78,720 Reduced 1.47%
5,285,226 $4.11 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $46.8 Million - $55.2 Million
89,168 Added 1.69%
5,363,946 $3.13 Billion
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $76 Million - $105 Million
174,753 Added 3.43%
5,274,778 $2.83 Billion
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $20.8 Million - $27.8 Million
-59,378 Reduced 1.15%
5,100,025 $2.39 Billion
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $38.3 Million - $45 Million
123,239 Added 2.45%
5,159,403 $1.77 Billion
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $31.5 Million - $36.7 Million
-98,034 Reduced 1.91%
5,036,164 $1.84 Billion
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $13.1 Million - $14.9 Million
-44,141 Reduced 0.85%
5,134,198 $1.66 Billion
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $27.8 Million - $32.6 Million
99,705 Added 1.96%
5,178,339 $1.68 Billion
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $149 Million - $186 Million
636,694 Added 14.33%
5,078,634 $1.47 Billion
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $30.6 Million - $37.9 Million
-135,923 Reduced 2.97%
4,441,940 $1.23 Billion
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $112 Million - $138 Million
-507,035 Reduced 9.97%
4,577,863 $1.06 Billion
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $45.1 Million - $58.3 Million
-249,534 Reduced 4.68%
5,084,898 $1.17 Billion
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $197 Million - $255 Million
-1,198,133 Reduced 18.34%
5,334,432 $997 Million
Q4 2020

May 17, 2021

SELL
$130.46 - $172.63 $4.46 Million - $5.9 Million
-34,152 Reduced 0.52%
6,532,565 $1.1 Billion
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $169 Million - $224 Million
-1,296,512 Reduced 16.49%
6,566,717 $1.11 Billion
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $23.9 Million - $27.7 Million
-163,638 Reduced 2.04%
7,863,229 $1.16 Billion
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $324 Million - $389 Million
2,372,251 Added 41.95%
8,026,867 $1.32 Billion
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $183 Million - $226 Million
1,533,024 Added 37.19%
5,654,616 $784 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $293 Million - $363 Million
-2,740,499 Reduced 39.94%
4,121,592 $542 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $43.1 Million - $46.9 Million
-403,753 Reduced 5.56%
6,862,091 $767 Million
Q2 2019

Aug 15, 2019

BUY
$110.79 - $129.32 $801 Million - $935 Million
7,229,751 Added 20030.9%
7,265,844 $805 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $35,730 - $42,057
-321 Reduced 0.88%
36,093 $4.68 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $31,134 - $34,880
-294 Reduced 0.8%
36,414 $4.21 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $61,733 - $77,155
-719 Reduced 1.92%
36,708 $3.94 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $21,574 - $24,760
285 Added 0.77%
37,427 $3.19 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $1,038 - $1,226
-14 Reduced 0.04%
37,142 $2.87 Million
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $26,958 - $28,915
-329 Reduced 0.88%
37,156 $0
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $2.89 Million - $3.21 Million
37,485
37,485 $3.21 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.